Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24(5):383–98.
Google Scholar
Havnes IA, Jørstad ML, McVeigh J, Van Hout MC, Bjørnebekk A. The anabolic androgenic steroid treatment gap: a National Study of Substance Use Disorder Treatment. Subst abuse: Res Treat. 2020;14:1178221820904150.
Pereira E, Moyses SJ, Ignácio SA, Mendes DK, Silva D, Carneiro E, et al. Prevalence and profile of users and non-users of anabolic steroids among resistance training practitioners. BMC Public Health. 2019;19(1):1650.
Google Scholar
van Amsterdam J, Opperhuizen A, Hartgens F. Adverse health effects of anabolic-androgenic steroids. Regul Toxicol Pharmacol. 2010;57(1):117–23.
Google Scholar
Thiblin I, Garmo H, Garle M, Holmberg L, Byberg L, Michaëlsson K, et al. Anabolic steroids and cardiovascular risk: a national population-based cohort study. Drug Alcohol Depend. 2015;152:87–92.
Google Scholar
Barbosa Neto O, da Mota GR, De Sordi CC, Resende E, Resende L, Vieira da Silva MA, et al. Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities. Clin Auton Res. 2018;28(2):231–44.
Google Scholar
Christoffersen T, Andersen JT, Dalhoff KP, Horwitz H. Anabolic-androgenic steroids and the risk of imprisonment. Drug Alcohol Depend. 2019;203:92–7.
Google Scholar
Hauger LE, Westlye LT, Bjørnebekk A. Anabolic androgenic steroid dependence is associated with executive dysfunction. Drug Alcohol Depend. 2020;208:107874.
Google Scholar
Hauger LE, Havnes IA, Jørstad ML, Bjørnebekk A. Anabolic androgenic steroids, antisocial personality traits, aggression and violence. Drug Alcohol Depend. 2021;221:108604.
Google Scholar
Christou MA, Christou PA, Markozannes G, Tsatsoulis A, Mastorakos G, Tigas S. Effects of anabolic androgenic steroids on the Reproductive system of athletes and recreational users: a systematic review and Meta-analysis. Sports Med. 2017;47(9):1869–83.
Google Scholar
Kanayama G, Kean J, Hudson JI, Pope HG Jr. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013;130(1–3):208–14.
Google Scholar
Kanayama G, Hudson JI, Pope HG. Jr. Features of men with anabolic-androgenic steroid dependence: a comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 2009;102(1–3):130–7.
Google Scholar
Ip EJ, Lu DH, Barnett MJ, Tenerowicz MJ, Vo JC, Perry PJ. Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2012;32(10):910–9.
Google Scholar
Brower KJ. Anabolic steroid abuse and dependence. Curr Psychiatry Rep. 2002;4(5):377–87.
Google Scholar
Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Jr. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry. 2009;166(6):642–5.
Google Scholar
Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Jr. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009;104(12):1966–78.
Google Scholar
Kashkin KB, Kleber HD. Hooked on hormones?: an anabolic steroid addiction hypothesis. JAMA. 1989;262(22):3166–70.
Google Scholar
Vassallo MJ, Olrich TW. Confidence by injection: male users of anabolic steroids speak of increases in perceived confidence through anabolic steroid use. Int J Sport Exerc Psychol. 2010;8(1):70–80.
Google Scholar
Hildebrandt T, Yehuda R, Alfano L. What can allostasis tell us about anabolic–androgenic steroid addiction? Dev Psychopathol. 2011;23(3):907–19.
Google Scholar
Mattina GF, Slyepchenko A, Steiner M. Obsessive-compulsive and related disorders. Handb Clin Neurol. 2020;175:369–86.
Google Scholar
Pope CG, Pope HG, Menard W, Fay C, Olivardia R, Phillips KA. Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image. 2005;2(4):395–400.
Google Scholar
Pope HG Jr, Gruber AJ, Choi P, Olivardia R, Phillips KA. Muscle dysmorphia: an underrecognized form of body dysmorphic disorder. Psychosomatics. 1997;38(6):548–57.
Google Scholar
Pope HG Jr, Katz DL, Hudson JI. Anorexia nervosa and “reverse anorexia” among 108 male bodybuilders. Compr Psychiatry. 1993;34(6):406–9.
Google Scholar
Nagata JM, McGuire FH, Lavender JM, Brown TA, Murray SB, Compte EJ, et al. Appearance and performance-enhancing drugs and supplements (APEDS): lifetime use and associations with eating disorder and muscle dysmorphia symptoms among cisgender sexual minority people. Eat Behav. 2022;44:101595.
Google Scholar
García-Rodríguez J, Alvarez-Rayón G, Camacho-Ruíz J, Amaya-Hernández A, Mancilla-Díaz JM. Muscle dysmorphia and use of ergogenics substances. A systematic review. Revista Colombiana de Psiquiatría (English ed). 2017;46(3):168–77.
Piacentino D, Kotzalidis GD, Longo L, Pavan A, Stivali L, Stivali G, et al. Body image and eating Disorders are common among professional and amateur athletes using performance and image enhancing drugs: a cross-sectional study. J Psychoactive Drugs. 2017;49(5):373–84.
Google Scholar
Mitchell L, Murray SB, Cobley S, Hackett D, Gifford J, Capling L, et al. Muscle Dysmorphia Symptomatology and Associated Psychological features in bodybuilders and Non-Bodybuilder Resistance Trainers: a systematic review and Meta-analysis. Sports Med. 2017;47(2):233–59.
Google Scholar
Longobardi C, Prino LE, Fabris MA, Settanni M. Muscle dysmorphia and psychopathology: findings from an italian sample of male bodybuilders. Psychiatry Res. 2017;256:231–6.
Google Scholar
Nieuwoudt JE, Zhou S, Coutts RA, Booker R. Symptoms of muscle dysmorphia, body dysmorphic disorder, and eating Disorders in a Nonclinical Population of Adult Male Weightlifters in Australia. J Strength Conditioning Res. 2015;29(5):1406–14.
Google Scholar
Hildebrandt T, Harty S, Langenbucher JW. Fitness supplements as a gateway substance for anabolic-androgenic steroid use. Psychol Addict Behav. 2012;26(4):955–62.
Google Scholar
Kanayama G, Pope HG Jr, Hudson JI. Associations of anabolic-androgenic steroid use with other behavioral disorders: an analysis using directed acyclic graphs. Psychol Med. 2018;48(15):2601–8.
Google Scholar
Kanayama G, Barry S, Hudson JI, Pope HG. Jr. Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry. 2006;163(4):697–703.
Google Scholar
Rohman L. The relationship between anabolic androgenic steroids and muscle dysmorphia: a review. Eat Disord. 2009;17(3):187–99.
Google Scholar
Griffiths S, Jacka B, Degenhardt L, Murray SB, Larance B. Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users. Drug Alcohol Rev. 2018;37(5):664–70.
Google Scholar
Skoufa L, Barkoukis V, Lazuras L, Tsorbatzoudis H. Effect of muscle dysmorphia on image-and-performance-enhancement drugs use intentions in a non-clinical sample: the role of social cognition. Perform Enhancement Health. 2021;9(3):100204.
Google Scholar
Fried EI, Robinaugh DJ. Systems all the way down: embracing complexity in mental health research. BMC Med. 2020;18(1):205.
Google Scholar
Borsboom D, Cramer AO. Network analysis: an integrative approach to the structure of psychopathology. Ann Rev Clin Psychol. 2013;9:91–121.
Google Scholar
Haslbeck JMB, Ryan O, Robinaugh DJ, Waldorp LJ, Borsboom D. Modeling psychopathology: From data models to formal theories. Psychological Methods. 2021:No Pagination Specified-No Pagination Specified.
Borsboom D. A network theory of mental disorders. World psychiatry. 2017;16(1):5–13.
Google Scholar
McNally RJ. Can network analysis transform psychopathology? Behav Res Ther. 2016;86:95–104.
Google Scholar
Fried EI, van Borkulo CD, Cramer AO, Boschloo L, Schoevers RA, Borsboom D. Mental disorders as networks of problems: a review of recent insights. Soc Psychiatry Psychiatr Epidemiol. 2017;52(1):1–10.
Google Scholar
Vanzhula IA, Kinkel-Ram SS, Levinson CA. Perfectionism and Difficulty Controlling Thoughts Bridge eating disorder and obsessive-compulsive disorder symptoms: A Network Analysis. J Affect Disord. 2021;283:302–9.
Google Scholar
Rhemtulla M, Fried EI, Aggen SH, Tuerlinckx F, Kendler KS, Borsboom D. Network analysis of substance abuse and dependence symptoms. Drug Alcohol Depend. 2016;161:230–7.
Google Scholar
Rutten RJT, Broekman TG, Schippers GM, Schellekens AFA. Symptom networks in patients with substance use disorders.Drug Alcohol Depend. 2021;229(Pt B):109080.
Summers BJ, Aalbers G, Jones PJ, McNally RJ, Phillips KA, Wilhelm S. A network perspective on body dysmorphic disorder and major depressive disorder. J Affect Disord. 2020;262:165–73.
Google Scholar
Prnjak K, Murray SB. The need for precision research on muscle dysmorphia: Special issue call for research on clinically diagnosed samples.Body Image. 2021.
Bjørnebekk A, Kaufmann T, Hauger LE, Klonteig S, Hullstein IR, Westlye LT. Long-term anabolic androgenic steroid use is associated with deviant brain aging. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging; 2021.
Google Scholar
Pope HG Jr, Kean J, Nash A, Kanayama G, Samuel DB, Bickel WK, et al. A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity. Exp Clin Psychopharmacol. 2010;18(3):203.
Google Scholar
Rhea DJ, Lantz CD, Cornelius AE. Development of the muscle Dysmorphia Inventory (MDI). J Sports Med Phys Fitness. 2004;44(4):428–35.
Google Scholar
R Core Team. R: a Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2022.
Epskamp S, Cramer AO, Waldorp LJ, Schmittmann VD, Borsboom D. qgraph: network visualizations of Relationships in Psychometric Data. J Stat Softw. 2012;48(4):2021.
Google Scholar
Bringmann LF, Elmer T, Epskamp S, Krause RW, Schoch D, Wichers M, et al. What do centrality measures measure in psychological networks? J Abnorm Psychol. 2019;128(8):892–903.
Google Scholar
Robinaugh DJ, Millner AJ, McNally RJ. Identifying highly influential nodes in the complicated grief network. J Abnorm Psychol. 2016;125(6):747.
Google Scholar
Fried EI, Eidhof MB, Palic S, Costantini G, Huisman-van Dijk HM, Bockting CL, et al. Replicability and generalizability of posttraumatic stress disorder (PTSD) networks: a cross-cultural multisite study of PTSD symptoms in four trauma patient samples. Clin Psychol Sci. 2018;6(3):335–51.
Google Scholar
Epskamp S, Borsboom D, Fried EI. Estimating psychological networks and their accuracy: a tutorial paper. Behav Res Methods. 2018;50(1):195–212.
Google Scholar
Epskamp S, Fried EI. Package ‘bootnet’. R package version. 2018;1.
Haoming Jiang XF, Han L, Roeder K, Lafferty J, Wasserman L, Li X. Tuo Zhao. huge: High-Dimensional Undirected Graph Estimation. R package version 1.3.5 ed2021.
van Borkulo C, Boschloo L, Borsboom D, Penninx B, Waldorp L, Schoevers R. Package ‘NetworkComparisonTest’.JAMA Psychiatry. 2015.
Piatkowski TM, White KM, Hides LM, Obst PL. Australia’s Adonis: understanding what motivates young men’s lifestyle choices for enhancing their appearance. Aust Psychol. 2020;55(2):156–68.
Google Scholar
Piatkowski TM, Dunn M, White KM, Hides LM, Obst PL. Exploring the harms arising from polysubstance use among performance and image enhancing drug users among young australian men. Perform Enhancement Health. 2021;9(3):100197.
Google Scholar
Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ. The anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for Strength Training. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2011;31(8):757–66.
Google Scholar
Bontempi L, Bonci A. µ-Opioid receptor–induced synaptic plasticity in dopamine neurons mediates the rewarding properties of anabolic androgenic steroids. Sci Signal. 2020;13(647):eaba1169.
Google Scholar
Morales M, Margolis EB. Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat Rev Neurosci. 2017;18(2):73–85.
Google Scholar
Johansson P, Ray A, Zhou Q, Huang W, Karlsson K, Nyberg F. Anabolic androgenic steroids increase β-endorphin levels in the ventral tegmental area in the male rat brain. Neurosci Res. 1997;27(2):185–9.
Google Scholar
Scarth M, Havnes IA, Jørstad ML, McVeigh J, Van Hout MC, Westlye LT, et al. Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway. Drug Alcohol Depend. 2022;231:109275.
Google Scholar
Baldacchino A, Balfour DJK, Passetti F, Humphris G, Matthews K. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci Biobehavioral Reviews. 2012;36(9):2056–68.
Google Scholar
Jenssen IH, Johannessen KB. Aggression and body image concerns among anabolic androgenic steroid users, contemplators, and controls in Norway. Body Image. 2015;12:6–13.
Google Scholar
Pope HG Jr, Kanayama G, Hudson JI. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2012;71(3):254–61.
Google Scholar
Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, et al. Cardiovascular toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017;135(21):1991–2002.
Google Scholar
Hildebrandt T, Alfano L, Langenbucher JW. Body image disturbance in 1000 male appearance and performance enhancing drug users. J Psychiatr Res. 2010;44(13):841–6.
Google Scholar
Corazza O, Simonato P, Demetrovics Z, Mooney R, van de Ven K, Roman-Urrestarazu A, et al. The emergence of Exercise Addiction, body dysmorphic disorder, and other image-related psychopathological correlates in fitness settings: a cross sectional study. PLoS ONE. 2019;14(4):e0213060.
Google Scholar
Griffiths S, Murray SB, Dunn M, Blashill AJ. Anabolic steroid use among gay and bisexual men living in Australia and New Zealand: Associations with demographics, body dissatisfaction, eating disorder psychopathology, and quality of life. Drug Alcohol Depend. 2017;181:170–6.
Google Scholar
Greenway CW, Price C. A qualitative study of the motivations for anabolic-androgenic steroid use: the role of muscle dysmorphia and self-esteem in long-term users. Perform Enhancement Health. 2018;6(1):12–20.
Google Scholar
Sagoe D, McVeigh J, Bjørnebekk A, Essilfie MS, Andreassen CS, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abuse Treat Prev Policy. 2015;10:12.
Google Scholar
Garcia-Argibay M. The Relationship between the big five personality traits, Impulsivity, and Anabolic Steroid Use. Subst Use Misuse. 2019;54(2):236–46.
Google Scholar
Murray SB, Griffiths S, Mond JM, Kean J, Blashill AJ. Anabolic steroid use and body image psychopathology in men: delineating between appearance- versus performance-driven motivations. Drug Alcohol Depend. 2016;165:198–202.
Google Scholar
Havnes IA, Jørstad ML, Wisløff C. Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires. Substance Abuse Treatment, Prevention, and Policy. 2019;14(1):20.
Horwitz H, Andersen JT, Dalhoff KP. Health consequences of androgenic anabolic steroid use. J Intern Med. 2019;285(3):333–40.
Google Scholar
Piacentino D, Kotzalidis GD, Del Casale A, Aromatario MR, Pomara C, Girardi P, et al. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol. 2015;13(1):101–21.
Google Scholar
Smit DL, Buijs MM, de Hon O, den Heijer M, de Ronde W. Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study. Hum Reprod. 2021;36(4):880–90.
Google Scholar
Griffiths S, Hay P, Mitchison D, Mond JM, McLean SA, Rodgers B, et al. Sex differences in the relationships between body dissatisfaction, quality of life and psychological distress. Aust N Z J Public Health. 2016;40(6):518–22.
Google Scholar
Roberto Olivardia PhD, Harrison G, Pope J,M.D., M.P.H.and, Hudson JI. Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry. 2000;157(8):1291–6.
Google Scholar
Robinaugh DJ, Hoekstra RHA, Toner ER, Borsboom D. The network approach to psychopathology: a review of the literature 2008–2018 and an agenda for future research. Psychol Med. 2020;50(3):353–66.
Google Scholar
Fried EI. Studying mental disorders as systems, not syndromes. PsyArXiv. 2021.